Literature DB >> 11276407

Adult attention deficit hyperactivity disorder.

S V Faraone1, M T Tsuang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11276407     DOI： 10.1007/s11920-001-0009-y

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN： 1523-3812            Impact factor:   5.285


× No keyword cloud information.
  11 in total

1.  Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder.

Authors:  T Spencer; J Biederman; T Wilens; J Prince; M Hatch; J Jones; M Harding; S V Faraone; L Seidman
Journal:  Am J Psychiatry       Date:  1998-05       Impact factor: 18.112

2.  A double-blind, placebo-controlled study of Adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder.

Authors:  S R Pliszka; R G Browne; R L Olvera; S K Wynne
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-05       Impact factor: 8.829

3.  A systematic assessment of tricyclic antidepressants in the treatment of adult attention-deficit hyperactivity disorder.

Authors:  T E Wilens; J Biederman; E Mick; T J Spencer
Journal:  J Nerv Ment Dis       Date:  1995-01       Impact factor: 2.254

4.  Differential effectiveness of methylphenidate and Adderall in school-age youths with attention-deficit/hyperactivity disorder.

Authors:  M J Manos; E J Short; R L Findling
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1999-07       Impact factor: 8.829

Review 5.  Attention-deficit/hyperactivity disorder in adults: an overview.

Authors:  S V Faraone; J Biederman; T Spencer; T Wilens; L J Seidman; E Mick; A E Doyle
Journal:  Biol Psychiatry       Date:  2000-07-01       Impact factor: 13.382

6.  A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.

Authors:  W E Pelham; H R Aronoff; J K Midlam; C J Shapiro; E M Gnagy; A M Chronis; A N Onyango; G Forehand; A Nguyen; J Waxmonsky
Journal:  Pediatrics       Date:  1999-04       Impact factor: 7.124

Review 7.  Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle.

Authors:  T Spencer; J Biederman; T Wilens; M Harding; D O'Donnell; S Griffin
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-04       Impact factor: 8.829

8.  Unrecognized attention-deficit hyperactivity disorder in adults presenting for outpatient psychotherapy.

Authors:  J J Ratey; M S Greenberg; J R Bemporad; K J Lindem
Journal:  J Child Adolesc Psychopharmacol       Date:  1992       Impact factor: 2.576

9.  Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder.

Authors:  T E Wilens; J Biederman; J Prince; T J Spencer; S V Faraone; R Warburton; D Schleifer; M Harding; C Linehan; D Geller
Journal:  Am J Psychiatry       Date:  1996-09       Impact factor: 18.112

10.  A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.

Authors:  T Spencer; T Wilens; J Biederman; S V Faraone; J S Ablon; K Lapey
Journal:  Arch Gen Psychiatry       Date:  1995-06
View more
  1 in total

1.  Study design, baseline patient characteristics and intervention in a cross-cultural framework: results from the ADORE study.

Authors:  Ulrich Preuss; Stephen J Ralston; Gisli Baldursson; Bruno Falissard; Maria J Lorenzo; Rob Rodrigues Pereira; Laurens Vlasveld; David Coghill
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-12       Impact factor: 4.785
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.